Exact Mass: 408.011
Exact Mass Matches: 408.011
Found 113 metabolites which its exact mass value is equals to given mass value 408.011,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Antibiotic MM4550
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
6-Hydroxy-5-[(4-sulfophenyl)azo]-2-naphthalenesulfonic acid
Yellow food dye used in cereals, bakery products, sweets, snack foods, ice cream, drinks and canned fish.
Flufenpyr-ethyl
CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4560; ORIGINAL_PRECURSOR_SCAN_NO 4556 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4524 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4508; ORIGINAL_PRECURSOR_SCAN_NO 4505 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4549; ORIGINAL_PRECURSOR_SCAN_NO 4546 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4523 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4501; ORIGINAL_PRECURSOR_SCAN_NO 4498 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9316; ORIGINAL_PRECURSOR_SCAN_NO 9312 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9375; ORIGINAL_PRECURSOR_SCAN_NO 9372 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9348; ORIGINAL_PRECURSOR_SCAN_NO 9345 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9386; ORIGINAL_PRECURSOR_SCAN_NO 9384 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9363; ORIGINAL_PRECURSOR_SCAN_NO 9362 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9405; ORIGINAL_PRECURSOR_SCAN_NO 9404
3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)piperazine-2-one
(6E,8E,12E)-3-methylene-4-oxo-7,11-dimethyl-(10S*,11R*)-dichloro-13-bromotrideca-6,8,12-trienoic acid|Polyhalogenated homosesquiterpenic fatty acid A
13-bromo-10R,11R-dichloro-7,11-dimethyl-3-methylene-4-oxo-6E,8E,12E-tridecatrienoic acid
13-bromo-10S,11R-dichloro-7,11-dimethyl-3-methylene-4-oxo-6E,8E,12E-tridecatrienoic acid
4-(2-Bromo-5-fluorophenoxy)-1-[5-(2H-tetrazol-5-yl)-3-isoxazolyl]piperidine
Cyclooctadiene(hydroquinone)rhodium(I)tetrafluoroborate
1-((2-(6-BROMOQUINOLIN-4-YL)-1-(PYRIDIN-2-YL)ETHYLIDENE)AMINO)PYRROLIDIN-2-ONE
1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8,8-dimethoxyoctane
Xanthosine 5-monophosphate sodium salt
Xanthosine 5'-monophosphate sodium salt (5'-Xanthylic acid sodium salt) is an intermediate in purine metabolism. Xanthosine 5'-monophosphate sodium salt can be used for genetic code, nucleic acid structure, and DNA, RNA and protein synthesis research[1].
ethyl 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylate
2,2-bis(3,5-difluoro-4-hydroxyphenyl)hexafluoropropane
3-Ethyl-2-(2-(phenylamino)vinyl)benzo[d]thiazol-3-ium iodide
Tranxene
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
(S)-2-Benzothiazolyl (Z)-2-(2-aminothiazole-4-yl)-2-methoxycarbonylmethoxyiminothioacetate
4-(chloromethyl)-6,8-difluoro-7-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
N-(4-Chloro-2-methylphenyl)-2-[(4-chloro-2-nitrophenyl)azo]-3-oxobutanamide
2-(4-Fluorophenyl)-5-[(5-iodo-2-Methylphenyl)methyl]thiophene
N-{(E)-[3-(benzyloxy)phenyl]methylidene}-4-bromobenzohydrazide
N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide
Benzyl glucosinolate
6-Hydroxy-5-((4-sulphophenyl)azo)naphthalene-2-sulphonic acid
D000074385 - Food Ingredients > D005503 - Food Additives > D005505 - Food Coloring Agents D004396 - Coloring Agents
N-[5-(1,3-benzothiazol-2-yl)-2-chlorophenyl]-1,3-benzodioxole-5-carboxamide
2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide
(6E)-6-(3-ethoxy-4-hydroxybenzylidene)-2-(ethylsulfonyl)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
2-(4-chlorophenoxy)-N-[[4-(3-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]acetamide
N-(1,3-benzodioxol-5-yl)-2-[2-(3-chloro-4-methylanilino)-2-oxoethyl]sulfinylacetamide
1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridin-1-ium-3,5-dicarbothioate
rel-3-((1S,2S,4R,6R,7S,9R,11R,12R)-2-Bromo-12-chloro-7-methyl-5,8,14-trioxa-tricyclo[9.2.1.0[4,6]]tetradec-9-yl)-acrylic acid methyl ester
A natural product found in Laurencia marilzae.
[4-(5-hydroxy-7-methoxy-8-methyl-4-oxo-4H-chromen-3-yl)-2-methoxyphenyl]oxidanesulfonic acid
[2-ethoxy-6-nitro-4-[(E)-(5-oxo-2-prop-2-enylsulfanyl-1,3-thiazol-4-ylidene)methyl]phenyl] acetate
(11-Methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaen-14-yl) hydrogen sulate
(Z)-3,4,4,5,5,6,6,7,7,8,8,9,9,9-tetradecafluoronon-2-enoic acid
glucotropeolin(1-)
An aralkylglucosinolate that is the conjugate base of glucotropeolin; major species at pH 7.3.
dipotassium clorazepate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
dADP(3-)
A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of 2-deoxyadenosine 5-diphosphate (dADP); major species at pH 7.3.
10074-A4
10074-A4 is a c-Myc inhibitor. 10074-A4 could bind to c-Myc370-409 at different sites along the peptide chain. 10074-A4 has anticancer effects[1][2].
3,8-dibromo-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene-4,11-diol
(5r)-5-[(1s,2e)-10,10-dibromo-1-methoxydeca-2,9-dien-1-yl]oxolan-2-one
8,8,8-trichloro-2,7-dimethyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(11e)-16-bromo-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione
(5r)-5-[(1e,3s)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
(5r,6r)-3-[(r)-(1e)-2-[(1-hydroxyethylidene)amino]ethenesulfinyl]-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(7s)-8,8,8-trichloro-2,7-dimethyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
5-(10,10-dibromo-3-methoxydeca-1,9-dien-1-yl)oxolan-2-one
(2e,4e)-8,8,8-trichloro-2,7-dimethyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
(5s)-5-[(1r,2e)-10,10-dibromo-1-methoxydeca-2,9-dien-1-yl]oxolan-2-one
(2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropoxysulfonic acid
3-{2-[(1-hydroxyethylidene)amino]ethenesulfinyl}-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4r,6r,8r,9z,11e)-16-bromo-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione
(6e,8e,10s,11r,12e)-13-bromo-10,11-dichloro-7,11-dimethyl-3-methylidene-4-oxotrideca-6,8,12-trienoic acid
(2e,4e,7s)-8,8,8-trichloro-2,7-dimethyl-n-[(1s)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
n-[2-(2-{[(4-bromophenyl)methoxy]carbonyl}-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-ylidene)ethyl]ethanimidic acid
(5s)-5-[(1e,3s)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
5,7-dichloro-4,12,14-trihydroxy-6-methyl-15-(3-methylbut-2-en-1-yl)-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-one
(6e,8e,10r,11r,12e)-13-bromo-10,11-dichloro-7,11-dimethyl-3-methylidene-4-oxotrideca-6,8,12-trienoic acid
4-(but-2-en-2-yl)-5,13-dichloro-14-hydroxy-6-methoxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
(5r)-5-[(1e,3r)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
3-[(1e)-2-[(1-hydroxyethylidene)amino]ethenesulfinyl]-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(1r,3s,4s,6s,8r,11r)-3,8-dibromo-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene-4,11-diol
5-(10,10-dibromo-1-methoxydeca-2,9-dien-1-yl)oxolan-2-one
(2s)-2-[(1r)-11,11-dibromo-1-methoxyundeca-2,10-dien-1-yl]oxolane
3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropoxysulfonic acid
13-bromo-10,11-dichloro-7,11-dimethyl-3-methylidene-4-oxotrideca-6,8,12-trienoic acid
(5s)-5-[(1e,3r)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
(2s)-2-[(1r,2e)-11,11-dibromo-1-methoxyundeca-2,10-dien-1-yl]oxolane
n-{2-[(2s,3z,5s)-2-{[(4-bromophenyl)methoxy]carbonyl}-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-ylidene]ethyl}ethanimidic acid
Dragonamide
Dragonamide is a fatty amide.
